A new wave of research highlights the potential of cannabis and its compounds to reduce the spread and severity of COVID-19 infections. In addition, cannabis may play a vital role in managing long COVID symptoms, including mental health issues and appetite loss. Researchers at Dalhousie University in Canada reviewed existing scientific literature, uncovering fascinating findings regarding marijuana as both a preventive and therapeutic aid, as published in the Journal of Clinical Medicine.
Cannabinoids, particularly, have shown promise in blocking the entry of the virus, reducing oxidative stress, and calming the severe immune response known as the "cytokine storm," a key feature of early COVID-19 infections. Following the fight with the virus, cannabinoids have been observed to alleviate post-COVID symptoms such as depression, anxiety, PTSD, insomnia, pain, and loss of appetite, providing hope for long COVID patients.
The research emphasizes efforts to close the knowledge gap regarding the endocannabinoid system (ECS) and its role during both the early and post-infection stages of COVID-19. While cannabis has been considered for acute treatment, this study suggests its potential in prevention and long-term recovery as well.